Ampio Pharmaceuticals Stock Price - AMPE

0.649
0.00 (0.00%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Ampio Pharmaceuticals Inc AMPE AMEX Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.0439 -6.34% 0.649 0.6151 0.69 0.69 0.6929 18:58:57
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
2,462 2,044,082 $ 0.648562 $ 1,325,714 1,007,621 0.26 - 1.31
Last Trade Time Type Quantity Stock Price Currency
20:00:00 3,900 $ 0.649 USD

Ampio Pharmaceuticals Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 102.96M 158.64M $ 33.99M 0.76 1.70 155.96M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
12.74M $ - 0.00% - -

more financials information »

Ampio Pharmaceuticals News

Loading Messages....

Latest AMPE Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical AMPE Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.690.7160.61510.6866321446,362-0.041-5.94%
1 Month0.780.790.60290.6858987792,314-0.131-16.79%
3 Months0.450.91010.370.62742841,099,4420.19944.22%
6 Months0.430.91010.260.5465276863,9740.21950.93%
1 Year0.68851.310.260.5200063852,600-0.0395-5.74%
3 Years0.91014.94990.261.161,018,567-0.2611-28.69%
5 Years5.759.010.261.57818,522-5.10-88.71%

Ampio Pharmaceuticals Description

Ampio Pharmaceuticals Inc is a biopharmaceutical company. The company focused primarily on developing compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds by affecting specific pathways at the protein expression and at the transcription level; activating specific phosphatase or depleting available phosphate needed for the inflammation process and decreasing vascular permeability. Ampio's leading product candidates are Ampion and Optina. It is currently conducting the second pivotal clinical trial in the United States for Ampion, a biologic intra-articular injection being studied for the treatment of osteoarthritis of the knee.


Your Recent History
AMEX
AMPE
Ampio Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.